Hepatitis B and C Prevalence in Afghanistan
Author Information
Author(s): Khan Sanaullah, Attaullah Sobia
Primary Institution: Kohat University of Science and Technology
Hypothesis
What is the prevalence of Hepatitis B and C in the Afghan population?
Conclusion
The study indicates that Afghanistan is at an early epidemic phase for Hepatitis B and C, with significant risk factors identified.
Supporting Evidence
- 1.9% of the Afghan population is estimated to be infected with Hepatitis B.
- 1.1% of the Afghan population is estimated to be infected with Hepatitis C.
- Injecting drug users and female sex workers are identified as the most at-risk populations.
Takeaway
This study looked at how many people in Afghanistan have Hepatitis B and C, and found that many are at risk because of drug use and unsafe practices.
Methodology
The review analyzed data from 31 studies conducted between 2003 and 2011, focusing on the prevalence of HBV and HCV in various populations.
Potential Biases
Potential biases include underreporting of cases and the exclusion of high-risk populations from studies.
Limitations
The study is limited by the lack of comprehensive data and the absence of sentinel surveillance in Afghanistan.
Participant Demographics
The study included various high-risk groups such as injecting drug users, female sex workers, and blood donors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website